Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

Equity highs and low credit spreads may be warning signs
August 10, 2026 / www.canadianminingreport.com

Gold stocks see strongest week in a decade
August 10, 2026 / www.canadianminingreport.com

Big Gold's strong Q2/26 results continue
August 03, 2026 / www.canadianminingreport.com

Gold stocks see moderate declines

August 03, 2026 / www.canadianminingreport.com

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok